Sections
| Title | Starting Page | Number of Pages |
|---|
| 1 Table of Contents | 2 | 8 |
| 1.1 List of Tables | 5 | 4 |
| 1.2 List of Figures | 9 | 1 |
| 2 Introduction | 10 | 1 |
| 2.1 Human Papillomavirus Diagnostic Tests Overview | 10 | 1 |
| 3 Products under Development | 11 | 5 |
| 3.1 Human Papillomavirus Diagnostic Tests - Pipeline Products by Stage of Development | 11 | 1 |
| 3.2 Human Papillomavirus Diagnostic Tests - Pipeline Products by Territory | 12 | 1 |
| 3.3 Human Papillomavirus Diagnostic Tests - Pipeline Products by Regulatory Path | 13 | 1 |
| 3.4 Human Papillomavirus Diagnostic Tests - Pipeline Products by Estimated Approval Date | 14 | 1 |
| 3.5 Human Papillomavirus Diagnostic Tests - Ongoing Clinical Trials | 15 | 1 |
| 4 Human Papillomavirus Diagnostic Tests - Pipeline Products under Development by Companies | 16 | 4 |
| 4.1 Human Papillomavirus Diagnostic Tests Companies - Pipeline Products by Stage of Development | 16 | 2 |
| 4.2 Human Papillomavirus Diagnostic Tests - Pipeline Products by Stage of Development | 18 | 2 |
| 5 Human Papillomavirus Diagnostic Tests Companies and Product Overview | 20 | 74 |
| 5.1 AutoGenomics, Inc. Company Overview | 20 | 1 |
| 5.1.1 AutoGenomics, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 20 | 3 |
| 5.2 Beckman Coulter, Inc. Company Overview | 23 | 1 |
| 5.2.1 Beckman Coulter, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 23 | 1 |
| 5.3 Becton, Dickinson and Company Company Overview | 24 | 1 |
| 5.3.1 Becton, Dickinson and Company Pipeline Products &Ongoing Clinical Trials Overview | 24 | 2 |
| 5.4 Biocartis SA Company Overview | 26 | 1 |
| 5.4.1 Biocartis SA Pipeline Products &Ongoing Clinical Trials Overview | 26 | 1 |
| 5.5 Biomagnetics Diagnostics Corporation (Inactive) Company Overview | 27 | 1 |
| 5.5.1 Biomagnetics Diagnostics Corporation (Inactive) Pipeline Products &Ongoing Clinical Trials Overview | 27 | 1 |
| 5.6 Bioorganic Research and Services S.A. Company Overview | 28 | 1 |
| 5.6.1 Bioorganic Research and Services S.A. Pipeline Products &Ongoing Clinical Trials Overview | 28 | 2 |
| 5.7 Bio-Techne Corp Company Overview | 30 | 1 |
| 5.7.1 Bio-Techne Corp Pipeline Products &Ongoing Clinical Trials Overview | 30 | 3 |
| 5.8 Cepheid Company Overview | 33 | 1 |
| 5.8.1 Cepheid Pipeline Products &Ongoing Clinical Trials Overview | 33 | 2 |
| 5.9 China Medical Technologies, Inc. Company Overview | 35 | 1 |
| 5.9.1 China Medical Technologies, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 35 | 2 |
| 5.10 Chronix Biomedical, Inc. Company Overview | 37 | 1 |
| 5.10.1 Chronix Biomedical, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 37 | 1 |
| 5.11 Co-Diagnostics HBDC, Inc. Company Overview | 38 | 1 |
| 5.11.1 Co-Diagnostics HBDC, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 38 | 1 |
| 5.12 Enigma Diagnostics Limited Company Overview | 39 | 1 |
| 5.12.1 Enigma Diagnostics Limited Pipeline Products &Ongoing Clinical Trials Overview | 39 | 1 |
| 5.13 Enzo Life Sciences, Inc. Company Overview | 40 | 1 |
| 5.13.1 Enzo Life Sciences, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 40 | 1 |
| 5.14 Genera Biosystems Limited Company Overview | 41 | 1 |
| 5.14.1 Genera Biosystems Limited Pipeline Products &Ongoing Clinical Trials Overview | 41 | 3 |
| 5.15 German Cancer Research Center Company Overview | 44 | 1 |
| 5.15.1 German Cancer Research Center Pipeline Products &Ongoing Clinical Trials Overview | 44 | 2 |
| 5.16 Goodgene Inc Company Overview | 46 | 1 |
| 5.16.1 Goodgene Inc Pipeline Products &Ongoing Clinical Trials Overview | 46 | 1 |
| 5.17 Great Basin Corporation Company Overview | 47 | 1 |
| 5.17.1 Great Basin Corporation Pipeline Products &Ongoing Clinical Trials Overview | 47 | 2 |
| 5.18 HEALTH BioMed Co., Ltd. Company Overview | 49 | 1 |
| 5.18.1 HEALTH BioMed Co., Ltd. Pipeline Products &Ongoing Clinical Trials Overview | 49 | 1 |
| 5.19 Homepoint Testing Company Overview | 50 | 1 |
| 5.19.1 Homepoint Testing Pipeline Products &Ongoing Clinical Trials Overview | 50 | 1 |
| 5.20 IncellDx, Inc. Company Overview | 51 | 1 |
| 5.20.1 IncellDx, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 51 | 2 |
| 5.21 KogeneBiotech Co Ltd Company Overview | 53 | 1 |
| 5.21.1 KogeneBiotech Co Ltd Pipeline Products &Ongoing Clinical Trials Overview | 53 | 1 |
| 5.22 MEDITE Cancer Diagnostics, Inc. Company Overview | 54 | 1 |
| 5.22.1 MEDITE Cancer Diagnostics, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 54 | 2 |
| 5.23 MedNostic Technologies, LLC Company Overview | 56 | 1 |
| 5.23.1 MedNostic Technologies, LLC Pipeline Products &Ongoing Clinical Trials Overview | 56 | 1 |
| 5.24 Molbio Diagnostics Pvt. Ltd. Company Overview | 57 | 1 |
| 5.24.1 Molbio Diagnostics Pvt. Ltd. Pipeline Products &Ongoing Clinical Trials Overview | 57 | 1 |
| 5.25 New Mexico Cancer Care Alliance Company Overview | 58 | 1 |
| 5.25.1 New Mexico Cancer Care Alliance Pipeline Products &Ongoing Clinical Trials Overview | 58 | 4 |
| 5.26 Novacyt Company Overview | 62 | 1 |
| 5.26.1 Novacyt Pipeline Products &Ongoing Clinical Trials Overview | 62 | 2 |
| 5.27 OncoHealth Corporation Company Overview | 64 | 1 |
| 5.27.1 OncoHealth Corporation Pipeline Products &Ongoing Clinical Trials Overview | 64 | 2 |
| 5.28 Pathogenica, Inc. Company Overview | 66 | 1 |
| 5.28.1 Pathogenica, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 66 | 1 |
| 5.29 Provista Diagnostics Inc. Company Overview | 67 | 1 |
| 5.29.1 Provista Diagnostics Inc. Pipeline Products &Ongoing Clinical Trials Overview | 67 | 2 |
| 5.30 Quidel Corporation Company Overview | 69 | 1 |
| 5.30.1 Quidel Corporation Pipeline Products &Ongoing Clinical Trials Overview | 69 | 2 |
| 5.31 Rheonix, Inc. Company Overview | 71 | 1 |
| 5.31.1 Rheonix, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 71 | 1 |
| 5.32 Roche Diagnostics International Ltd. Company Overview | 72 | 1 |
| 5.32.1 Roche Diagnostics International Ltd. Pipeline Products &Ongoing Clinical Trials Overview | 72 | 3 |
| 5.33 Roche Molecular Systems, Inc. Company Overview | 75 | 1 |
| 5.33.1 Roche Molecular Systems, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 75 | 2 |
| 5.34 Sansure Biotech Inc Company Overview | 77 | 1 |
| 5.34.1 Sansure Biotech Inc Pipeline Products &Ongoing Clinical Trials Overview | 77 | 2 |
| 5.35 Seattle Children s Research Institute Company Overview | 79 | 1 |
| 5.35.1 Seattle Children s Research Institute Pipeline Products &Ongoing Clinical Trials Overview | 79 | 1 |
| 5.36 Seegene, Inc. Company Overview | 80 | 1 |
| 5.36.1 Seegene, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 80 | 2 |
| 5.37 Sequenom, Inc. Company Overview | 82 | 1 |
| 5.37.1 Sequenom, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 82 | 3 |
| 5.38 The Feinstein Institute for Medical Research Company Overview | 85 | 1 |
| 5.38.1 The Feinstein Institute for Medical Research Pipeline Products &Ongoing Clinical Trials Overview | 85 | 1 |
| 5.39 The University of Queensland Company Overview | 86 | 1 |
| 5.39.1 The University of Queensland Pipeline Products &Ongoing Clinical Trials Overview | 86 | 1 |
| 5.40 TrovaGene, Inc. Company Overview | 87 | 1 |
| 5.40.1 TrovaGene, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 87 | 2 |
| 5.41 University of Texas at Austin Company Overview | 89 | 1 |
| 5.41.1 University of Texas at Austin Pipeline Products &Ongoing Clinical Trials Overview | 89 | 1 |
| 5.42 ValiRx Plc Company Overview | 90 | 1 |
| 5.42.1 ValiRx Plc Pipeline Products &Ongoing Clinical Trials Overview | 90 | 2 |
| 5.43 Yale University Company Overview | 92 | 1 |
| 5.43.1 Yale University Pipeline Products &Ongoing Clinical Trials Overview | 92 | 2 |
| 6 Human Papillomavirus Diagnostic Tests - Recent Developments | 94 | 21 |
| 6.1 Sep 27, 2016: ValiRx: Half Yearly Report for the Period Ended 30 June 2016 | 94 | 2 |
| 6.2 Sep 13, 2016: ValiRx: Quarterly Update On Clinical Developments | 96 | 1 |
| 6.3 Sep 06, 2016: BD Submits Pre-Market Approval Application to FDA for BD Onclarity HPV Test | 97 | 1 |
| 6.4 Sep 02, 2016: Danaher to Acquire Cepheid | 97 | 1 |
| 6.5 Aug 04, 2016: Trovagene Reports Second Quarter 2016 Financial Results and Accomplishments | 98 | 1 |
| 6.6 Aug 04, 2016: BD Announces Results For 2016 Third Fiscal Quarter | 99 | 1 |
| 6.7 Jul 28, 2016: QIAGEN Reports Results for Second Quarter of 2016; Increased Commitment to Return $300 Million of Capital to Shareholders by End-2017 | 100 | 3 |
| 6.8 Jul 28, 2016: BD Names R. Andrew Eckert To Board Of Directors | 103 | 1 |
| 6.9 Jul 28, 2016: Cepheid Reports Second Quarter 2016 Results | 104 | 1 |
| 6.10 Jul 27, 2016: Hologic Announces Financial Results for Third Quarter of Fiscal 2016 | 104 | 2 |
| 6.11 Jul 27, 2016: Quidel Reports Second Quarter 2016 Financial Results | 106 | 1 |
| 6.12 Jul 11, 2016: David Coorey Joins Agena Bioscience to Lead Europe, Middle East, and Africa Business | 107 | 1 |
| 6.13 Jul 06, 2016: Bio-Techne Acquires Advanced Cell Diagnostics | 108 | 1 |
| 6.14 Jul 04, 2016: Exiqon Nomination of candidates for the supervisory board | 108 | 1 |
| 6.15 Jun 21, 2016: Genera Biosystems provides update on PapType HPV test | 108 | 1 |
| 6.16 May 25, 2016: MEDITE Cancer Diagnostics Raises USD0.15 Million in Venture Financing | 109 | 1 |
| 6.17 May 10, 2016: Trovagene Announces First Quarter 2016 Financial Results | 109 | 1 |
| 6.18 May 09, 2016: Novacyt Enters into Clinical Trial Agreement with St Stephen s AIDS Trust | 110 | 1 |
| 6.19 Feb 15, 2016: Novacyt to Collaborate to Validate HPV Testing with NOVAprep Technology | 110 | 1 |
| 6.20 Feb 03, 2016: NEUMANN Diagnostics automated cervical cancer test achieves exceptional accuracy | 111 | 1 |
| 6.21 Feb 01, 2016: Updated cervical cancer screening guidelines from leading ob-gyn society support expanded use of cobas HPV Test for primary screening | 111 | 1 |
| 6.22 Jan 04, 2016: Seegene s HPV DNA assay proves its excellent performance in WHO global HPV LabNet study | 112 | 1 |
| 6.23 Nov 12, 2015: New Modeling Analysis Shows Screening for Cervical Cancer with Pap+HPV Together Could Provide Better Clinical and Economic Outcomes than Screening with HPV Alone | 112 | 2 |
| 6.24 Oct 12, 2015: Roche Wins the first HPV Primary Screening Tender in Europe | 114 | 1 |
| 7 Appendix | 115 | 4 |
| 7.1 Methodology | 115 | 2 |
| 7.2 About GlobalData | 117 | 1 |
| 7.3 Contact Us | 117 | 1 |
| 7.4 Disclaimer | 118 | 1 |